Table 3. Animal experimental design for vaccine efficacy evaluation using the developed FAdV-4 challenge model

Group No1) Immunization Challenge
Age (d) Virus Virus titer (TCID50/dose) Route Age (d) Virus Virus titer (TCID50/dose) Route
A 9 1 FAdV-4 4.54 × 106 PO 14 YS4 6.31 × 108 IM
B 9 1 FAdV-4 4.54 × 106 PO 14
C 9 1 14 YS4 6.31 × 108 IM
D 9 1 14
Number of chickens.
FAdV-4, fowl adenovirus serotype-4; PO, per os; IM, intramuscular.